Bendeka 100 mg/4 mL injection for intravenous infusion Images
Generic Name: bendamustine
This medication has been identified as Bendeka 100 mg/4 mL injection for intravenous infusion and is used for Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia. It belongs to the drug class alkylating agents and is not a controlled substance.
Images of medication
Bendeka
- Generic Name
- bendamustine
- Strength
- 100 mg/4 mL injection for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 63459-0348
See also:
More about Bendeka (bendamustine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.